This HTML5 document contains 68 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n8http://localhost/temp/predkladatel/
n16http://linked.opendata.cz/resource/domain/vavai/projekt/
n15http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n10http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n7http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11120%2F08%3A00001283%21RIV09-MZ0-11120___/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n17http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n11http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n5http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n12http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11120%2F08%3A00001283%21RIV09-MZ0-11120___
rdf:type
n10:Vysledek skos:Concept
dcterms:description
In the HD15 trial of the German Hodgkin Study Group, the negative predictive value (NPV) of positron emission tomography (PET) using [F-18]-fluorodeoxyglucose in advanced-stage Hodgkin lymphoma (HL) was evaluated. A total of 817 patients were enrolled and randomly assigned to receive BEACOPP-based chemotherapy. After completion of chemotherapy, residual disease measuring more than or equal to 2.5 cm in diameter was assessed by PET in 311 patients. The NPV of PET was defined as the proportion of PET- patients without progression, relapse, or irradiation within 12 months after PET review panel. The progression-free survival was 96% for PET- patients (95% confidence interval [CI], 94%-99%) and 86% for PET- patients (95% CI, 78%-95%, P = .011). The NPV for PET in this analysis was 94% (95% CI, 91%-97%). Thus, consolidation radiotherapy can be omitted in PET- patients with residual disease without increasing the risk for progression or early relapse compared with patients in complete remission. The impact Autoři popisují negativní vliv pozitronového emisního tomografu na progresi raného relapsu pro pacienty s reziduálním onemocněním po první řadě chemoterapie u pokročilých stádií Hodgkinova lymfomu In the HD15 trial of the German Hodgkin Study Group, the negative predictive value (NPV) of positron emission tomography (PET) using [F-18]-fluorodeoxyglucose in advanced-stage Hodgkin lymphoma (HL) was evaluated. A total of 817 patients were enrolled and randomly assigned to receive BEACOPP-based chemotherapy. After completion of chemotherapy, residual disease measuring more than or equal to 2.5 cm in diameter was assessed by PET in 311 patients. The NPV of PET was defined as the proportion of PET- patients without progression, relapse, or irradiation within 12 months after PET review panel. The progression-free survival was 96% for PET- patients (95% confidence interval [CI], 94%-99%) and 86% for PET- patients (95% CI, 78%-95%, P = .011). The NPV for PET in this analysis was 94% (95% CI, 91%-97%). Thus, consolidation radiotherapy can be omitted in PET- patients with residual disease without increasing the risk for progression or early relapse compared with patients in complete remission. The impact
dcterms:title
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma Pozitronový emisní tomograf má negativní prediktivní hodnoty pro progresi raného relapsu pro pacienty s reziduálním onemocněním po první řadě chemoterapie u pokročilých stádií Hodgkinova lymfomu Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma
skos:prefLabel
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma Pozitronový emisní tomograf má negativní prediktivní hodnoty pro progresi raného relapsu pro pacienty s reziduálním onemocněním po první řadě chemoterapie u pokročilých stádií Hodgkinova lymfomu
skos:notation
RIV/00216208:11120/08:00001283!RIV09-MZ0-11120___
n3:aktivita
n11:P
n3:aktivity
P(NR8033)
n3:cisloPeriodika
10
n3:dodaniDat
n12:2009
n3:domaciTvurceVysledku
n15:4504992
n3:druhVysledku
n5:J
n3:duvernostUdaju
n13:S
n3:entitaPredkladatele
n7:predkladatel
n3:idSjednocenehoVysledku
387756
n3:idVysledku
RIV/00216208:11120/08:00001283
n3:jazykVysledku
n17:eng
n3:klicovaSlova
FDG-PET; free survival; early interim; therapy; regimen; radiotherapy; metaanalysis; standard; cycles; trials
n3:klicoveSlovo
n4:FDG-PET n4:cycles n4:standard n4:therapy n4:metaanalysis n4:free%20survival n4:radiotherapy n4:trials n4:early%20interim n4:regimen
n3:kodStatuVydavatele
US - Spojené státy americké
n3:kontrolniKodProRIV
[FB6F770C0EB3]
n3:nazevZdroje
Blood
n3:obor
n18:FD
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
21
n3:projekt
n16:NR8033
n3:rokUplatneniVysledku
n12:2008
n3:svazekPeriodika
112
n3:tvurceVysledku
Amthauer, H. Kobe, C. Engert, A. Weckesser, M. Schicha, H. Borchmann, P. Bockisch, A. Diehl, V. Eich, H. T. Marková, Jana Franklin, J. Bares, R. Klutmann, S. Schreckenberger, M. Knapp, W. H. Lorenz, R. Fuchs, M. Zijlstra, J. M. Müller, R. P. Dietlein, M. Lohri, A.
n3:wos
000260691300016
s:issn
0006-4971
s:numberOfPages
6
n8:organizacniJednotka
11120